AzTrials
AzTrials

Lower Back PainNCT07040397

Electronic Approach to the Human Massage Therapist

A study testing EMMA massage therapy and Clinical massage treatment in people with Lower Back Pain, run by Mayo Clinic at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to gather information about patient experience receiving a massage through a robotic EMMA (Expert Manipulative Massage Automation) compared to receiving a massage from a massage therapist. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lower Back Pain
What is being tested?
EMMA massage therapy and Clinical massage treatment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
30 Jan 2026to 1 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • be 18 years of age or older.
  • report a primary pain point in the lower back.
  • Pain intensity reported at baseline
  • Women of childbearing potential who self-report not being pregnant and agree to employ an effective method of birth control (surgical sterilization or oral contraceptives, barrier method with spermicides, intrauterine device, etc.) during the study period
  • be able to participate fully in all aspects of the study.
  • have understood and signed study informed consent.

Who cannot join

  • Pregnancy or breastfeeding
  • Patients with the inability to stay in a prone position
  • Patients with bleeding disorders
  • Patients with allergies and/or local skin affectations
  • have used pain medications or participated in a pain treatment within three days of study enrollment.
  • have an implanted device (including a lap band) in the targeted area of massage therapy.
Show all 12Show fewer
  • have used an investigational drug within 30 days of study enrollment.
  • have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease.
  • have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, metabolic disease (such as uncontrolled diabetes type 2) active cancer, actively receiving treatment for cancer or within 1 year of cancer remission.
  • surgical intervention for pain within 1 month prior to enrollment.
  • active infection, wound or other external trauma to the areas to be treated with massage therapy.
  • have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905

    Pearl Buabeng, 507-266-1213, GIMResearchStudies@Mayo.edu

    Michael Mueller

    Recruiting

Other trials in United States

About this study

Official title: Comparing an Electronic Approach to the Human Massage Therapist.

The purpose of this study is to gather information about patient experience receiving a massage through a robotic EMMA (Expert Manipulative Massage Automation) compared to receiving a massage from a massage therapist.

Read the detailed description

Patients being evaluated in an outpatient service will be invited to participate in this study if they report a primary pain point in Low Back. Once they are enrolled in the study, they will be randomized to the type of massage therapy they will receive. Direct massage therapy through a certified massage therapist or indirect massage therapy through EMMA operated by a certified massage therapist.

Conditions
Lower Back Pain
Being tested
EMMA massage therapy, Clinical massage treatment
Keywords
massage, Low Back Pain, automated massage, EMMA (expert manipulative massage automation), electric massager
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EMMA massage therapyDevice

    Expert Manipulative Massage Automation (EMMA) is equipped with sensors to measure muscle stiffness and uses 3D vision technology to measure muscle stiffness and identify pressure points while delivering a massage to patients. Following that, the electronic massager will determine the best course of action for our patients based on the information stored by our Artificial Intelligence and EMMA's robotic arm will perform the massage. EMMA executes massages through soft treatment modules that are warmed to a temperature of between 38℃ and 40℃ to mimic human touch.

  • Clinical massage treatmentOther

    The direct person clinical massage treatment will be delivered by a clinical licensed massage therapist. The type of massage will follow the EMMA massage in that it will be a deep tissue massage (to mimic the Tuina massage) and generally will be for about 30 minutes to once again mimic the duration of massage therapy of the EMMA.

Study groups in NCT07040397
Study groupRoleWhat they receive
Indirect person massage therapyExperimentalA massage therapist will program and direct an Artificial Intelligence Robotic Arm (EMMA) to deliver massage therapy. EMMA executes massages through soft treatment modules that are warmed to a temperature of between 38℃ and 40℃ to mimic human touch. This treatment will last approximately 20 minutes.
Receives: Device: EMMA massage therapy
Direct person massage therapyActive comparatorClinical massage treatment procedures are delivered by a clinically licensed massage therapist. This treatment will last approximately 20 minutes.
Receives: Other: Clinical massage treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients enrolled

    Feasibility will be determined by the total number of patients screened in order to accrue the 40 needed to complete the study.

    Measured: baseline to end of study (year 2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2025
  2. Study start30 Jan 2026
  3. Primary completion1 Jun 2027 (estimated)
  4. Study completion1 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
20 will be randomized to EMMA and 20 to a certified massage therapist. Everyone will receive a massage treatment.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07040397
Sponsor's protocol ID
25-002863
Status last verified
Oct 2026
First submitted
5 Jun 2025
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing EMMA massage therapy and Clinical massage treatment in people with Lower Back Pain, run by Mayo Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients enrolled (time frame: baseline to end of study (year 2)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in